KYTX Kyverna Therapeutics, Inc.
$4.48
Kyverna Therapeutics, Inc. (KYTX) Earnings News
Earnings press releases, previews and reviews for Kyverna Therapeutics, Inc. (KYTX), newest first.
Thursday
November 12, 2026
8:00 AM ET
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results
Tuesday
August 11, 2026
4:02 PM ET
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results